SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-22-057365
Filing Date
2022-05-09
Accepted
2022-05-09 12:54:19
Documents
14
Period of Report
2022-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2214785d2_8ka.htm   iXBRL 8-K/A 28079
2 EXHIBIT 99.1 tm2214785d2_ex99-1.htm EX-99.1 110047
6 GRAPHIC tm2214785d2_ex99-1img01.jpg GRAPHIC 2915
  Complete submission text file 0001104659-22-057365.txt   333004

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fold-20220509.xsd EX-101.SCH 3063
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fold-20220509_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fold-20220509_pre.xml EX-101.PRE 22615
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2214785d2_8ka_htm.xml XML 3484
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

IRS No.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-33497 | Film No.: 22904139
SIC: 2834 Pharmaceutical Preparations